Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Benzoic acid
Cat. No.:
OB0225LY-0246
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Benzoic acid is a natural organic acid that conjugates with glycine in the liver.
Synonym:
Dracylic acid; FEMA 2131; 65-85-0; Benzenecarboxylic acid; Carboxybenzene; Benzeneformic acid
CAS No.:
65-85-0
Compound CID:
243
Formula:
C7H6O2
Formula Weight:
122.12
Specification
Relative Density:
1.321 g/cm3 at 20°C.;1.082 g/cm3 at 122.375°C;1.029 g/cm3 at 180°C.
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Benzoic acid can be used to evaluate the effectiveness and safety of preservatives.
Library Information
Targets:
Antifungal; Antibacterial
Pathways:
Microbiology/Virology; Metabolism
Plate Number:
AOCL-4
Plate Location:
a11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 491.32 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
24 mg/mL; 196.52 mM
